The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondary progressive multiple sclerosis, researchers reported in the New England Journal ...

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of ...

Roche Holdings AG RHHBY on Monday shared new late-breaking data from the Phase 3 FENtrepid study of the investigational ...

In people with early MS, diet may correlate with biological aging and the development of disease-related disability, study ...

Background Physical activity has been associated with neuroprotective and immunomodulatory benefits, potentially influencing ...

Panelists discuss how progression independent of relapse activity (PIRA) represents a distinct pathological process involving smoldering inflammation and neurodegeneration that drives disability in ...

Researchers developed a mouse model of multiple sclerosis that captures the features of progression independent of relapse ...

In a recent study published in Neurology - Neuroimmunology Neuroinflammation, researchers investigated the impact of coronavirus disease 2019 (COVID-19) on the progression of clinical disability in ...

Using eye-tracking -- a technique for recording and analyzing eye movements -- a team has shown that individuals with multiple disabilities can improve their social and emotional skills. Although ...

DEDHAM - A Dedham woman is trying to take the stigma out of disability aids. Noelle Connolly has been living with multiple sclerosis symptoms since she was 17 and was officially diagnosed at 23. "I ...

Share on Pinterest Scientists are trying to find blood biomarkers that may help predict the course of disease in MS. Betsie Van der Meer/Getty Images As of 2020, about 2.8 million people globally have ...

Please provide your email address to receive an email when new articles are posted on . Medical student burnout is an important quality assessment metric in medicine. Students with multiple ...